- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
COVID-19 & Racism: The Impact Of Two Pandemics On Nephrology Care
Did you know that COVID-19 is affecting Black, Indigenous, Latinx and other people of color more than Caucasians? Did you know that in the United States, Black people are dying at 2.5 times the rate of White people?1
Please join us for a virtual panel discussion, led by nephrology and mental health experts from across the country, where you can hear about the intersectional effects of COVID-19 on both patients and the mental health of providers. Panelists will highlight the structural inequities that have led to racial disparities in both COVID-19 and nephrology care and discuss potential solutions to help bridge the gap.
1.The COVID Tracking Project. (2020). The COVID Racial Data Tracker. Retrieved July 30, 2020, from https://covidtracking.com/race/
*Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Saba Gidey, PharmD, BCPS and Tazin Aijaz, PharmD, BCPS are employees of OPDC.
To register for this event please visit http://www.annasymposium.org/.
Featured Speakers
Saundra Jain, MA, PsyD, LPC*
Clinical Assistant Professor at Nova Southeastern University School of Medicine and Nephrologist at Kidney & Hypertension Group of South Florida
Debra Hain, PhD, APRN, AGPCNP-BC, FAAN, FAANP, FNKF*
Professor at Florida Atlantic University College of NursingDr. Hain is a Ph.D. trained, board certified adult and gerontological nurse practitioner who has practice experience within nephrology nursing, memory disorder clinic and hospice care. Dr. Hain’s scholarly endeavors have focused on improving health outcomes of older adults with chronic kidney disease and those with cognitive impairment, and she has authored numerous peer reviewed publications on these topics. Her current research interests are strategies to improve self-management in an ethnically diverse population with CKD Stage 4 and 5 and Supportive (Palliative) care of older adults with CKD stage 4-5 and ESRD. Dr. Hain’s teaching has focused on care of individuals with chronic disease such as diabetes, chronic kidney disease, pulmonary disease, and cognitive impairment.
Charlotte Jones-Burton, MD, MS
Vice President of Global Clinical Development (Nephrology)-
Otsuka Pharmaceutical Companies (U.S.) & Women of Color in Pharma, Founder*
Dr Jones-Burton is an entrepreneurial pharmaceutical executive, has brought innovation and passion to her diverse roles within the healthcare industry over the last 20+ years as clinical development leader, internal medicine and nephrology physician, academician and change agent. In a top biopharmaceutical company, Dr Jones-Burton leads cross-functional teams to design, implement, and oversee clinical trial studies for innovative medicines. She has also achieved a high level of success as an entrepreneur in direct sales and franchise industries. Dr Jones-Burton excels in building and empowering diverse teams that deliver business results and has received numerous awards, including the new business developer award which was awarded to one of her teams.
Saba Gidey, PharmD, BCPS*
Senior Medical Science Liaison
Tazin Aijaz, PharmD, BCPS
Nephrology Medical Science DirectorOtsuka Pharmaceutical Development & Commercialization, Inc.*
Tazin Aijaz, PharmD, BCPS, is a Nephrology Medical Science Director at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy from the University of Cincinnati in Cincinnati, Ohio and then completed her clinical residency training at the Atlanta VA Medical Center with a focus in internal medicine and psychiatry. Prior to joining Otsuka, Dr Aijaz held various positions within the pharmaceutical industry in several therapeutic areas including immunology, movement disorders, and epilepsy.
Location
Online Via AnnaSymposium.org
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
